Novel Antithrombotics and Lower Risk of Intraocular Bleeding Novel Antithrombotics and Lower Risk of Intraocular Bleeding

Novel antithrombotics such as dabigatran or rivaroxaban are associated, in some instances, with a decreased risk of intraocular hemorrhage compared with traditional anticoagulant therapy.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Ophthalmology News Source Type: news